The present study focused on the degradation of antibiotic Chloramphenicol (CAP), an emerging contaminant, using submerged thermal plasma (STP) technology. Almost 99 % degradation and 82 % mineralization were achieved within 20 min of treatment by Ar/CO2 plasma, generated at 6.2 kW discharge power using a customized thermal plasma torch inside the aqueous solution. Kinetic analysis revealed first-order reaction for CAP degradation with a rate constant of 0.257 min−1. Long-lived species, such as H2O2, O3, NO2–, NO3–, and Cl- formed during plasma treatment were quantified. LaMnO3 perovskite (LMO) nanopowder prepared through a novel thermal plasma route, was introduced as catalyst into the treatment system which enhanced the degradation and mineralization efficiency by 34 % and 17 %, respectively, showing a strong synergetic effect between STP and catalyst. The energy yield was elevated from 102 mg/kWh to 144 mg/kWh with the addition of catalyst into the STP treatment system. Liquid chromatography-mass spectroscopy was used to identify the various degradation intermediates produced during thermal plasma treatment and correspondingly possible degradation pathways were proposed. The antibacterial activity assessment results revealed a significant reduction in the antimicrobial activity of all treated solutions against Gram-positive Bacillus cereus and Gram-negative Pseudomonas aeruginosa bacteria. Additionally, seed germination and growth assessment revealed a reduction in phytotoxicity of the treated solutions. STP, combined with the LMO, proved highly effective in treating pharmaceutical contamination in aqueous medium.